Health Tech Company Hygieia Adds to Its Unique System for Insulin Management

Livonia, Mich., March 30, 2020 — Hygieia, a Michigan-based health tech company for insulin management, is adding to its roster as the population of people with Type 2 diabetes who need insulin grows. Hygieia’s d-Nav® Insulin Management System uses artificial intelligence and patented technology to help people manage blood sugar levels.

Veteran health care executive Robert Frank, M.D., has joined Hygieia as chief medical officer where he will help connect the d-Nav system with physicians, health plans and health systems, both locally and nationally.  Dr. Frank, a cardiac surgeon, is the former CEO of the Wayne State University Physician Group as well as chief medical officer and EVP at Meridian Health Plan. Most recently, he was chief medical officer at Ampersand Health, based in Nashville, Tenn.

“Bob is a proven clinical leader who brings extensive health plan experience to our team. His insight into both client and patient needs will strengthen our product and service as we prepare to make the d-Nav® system available nationally,” said Eran Bashan, Ph.D., CEO of Hygieia.

The d-Nav system turns the tables on the old standard of insulin therapy. The d-Nav® system uses artificial intelligence to prescribe the appropriate insulin dose each time a patient prepares to inject.  The result is safe and effective insulin treatment that has nearly 90 percent of patients seeing improved A1c levels within 90 days. Ongoing monitoring can be done virtually, so patients can stay on track even while following stay-at-home practices for COVID-19.

“The current standard of insulin therapy gives patients limited ability to modify their insulin prescription until they are able to see their doctor for evaluation and dose adjustments. But the body’s insulin needs are dynamic and often require more frequent titration,” said Bashan. “The d-Nav system enables a person’s insulin dose to be adjusted more frequently, so people are getting more appropriate doses to meet their needs.”

Hygieia was founded by Bashan and Israel Hodish, M.D., Ph.D., when they were researchers at the University of Michigan. Driven by a singular focus of making insulin work better, they developed artificial intelligence that can prescribe insulin dose adjustments. With primary care physician time at a premium, and appointments with endocrinologists scheduled months in advance, Hygieia’s innovation creates a clinical system offered in a simple, AI-powered application.

As glucose results are entered into the d-Nav app, the app uses a proprietary algorithm to prescribe the appropriate amount of insulin to inject at that moment.  Users lower their A1c levels; they feel better; have fewer complications; reduce their medical costs and spend less time in physician offices.

In the United States last year, roughly $14 billion was spent on insulin. Yet, roughly half of insulin users are not reaching their A1c goal of less than 7 percent. This can cause additional health challenges and expenses.

The d-Nav specific focus on insulin titration will aid physicians in caring for patients with long-term, difficult to manage Type 2 diabetes. For more information on Hygieia’s d-Nav Insulin Management System, contact or 734-369-9980.

About Hygieia/ d-Nav Insulin Management System

Hygieia’s d-Nav® Insulin Management System includes an AI-powered application and helps people with Type 2 diabetes use insulin in a safe and effective way to control their glucose levels.  Nearly 90 percent of people using d-Nav® see improved A1c levels within three months. The d-Nav® Insulin Management System was developed at the University of Michigan and has been peer-reviewed with studies published in leading medical journals. Hygieia is headquartered in Livonia, Michigan. Learn more at

# # #

Media Contact:

Debbie Reinheimer,, 248-227-3667

Kathy Bilitzke,, 248-980-4597